Short answer
CME Group (CME) filed an 8-K current report with the SEC on September 9, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). Jack Tobin named Deputy CFO November 2, 2026, then CFO in March 2027.
CME Group 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Jack Tobin named Deputy CFO November 2, 2026, then CFO in March 2027
- Planned retirement deferred, preserving finance leadership continuity through succession
- Lynne Fitzpatrick’s transition to CEO in March 2027 creates coordinated executive succession
- Matthew Render becomes Chief Accounting Officer November 2, 2026, succeeding Tobin
- Tobin and Render receive standard compensation terms, with no disclosed related-party arrangements for Render
Item EX-99.1 · Exhibit EX-99.1
- Jack Tobin becomes CFO in March 2027, succeeding Lynne Fitzpatrick as she becomes CEO
- Tobin becomes Deputy CFO in November 2026, supporting an extended finance leadership transition
- Matthew Render succeeds Tobin as Chief Accounting Officer after joining CME in August 2026
- John Marchese becomes General Counsel later in September 2026, replacing Jonathan Marcus
- Internal promotions signal leadership continuity across finance and legal functions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CME Group 8-K filings
Get the next CME 8-K as it lands
Follow CME for push alerts, or ask the research agent what this filing means.